Lifeworks Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $996K | Sell |
1,897
-7,012
| -79% | -$3.68M | 0.15% | 129 |
|
|
2025
Q1 | $5.65M | Buy |
8,909
+2,166
| +32% | +$1.37M | 0.94% | 29 |
|
|
2024
Q4 | $4.8M | Buy |
6,743
+1,617
| +32% | +$1.15M | 0.87% | 32 |
|
|
2024
Q3 | $5.39M | Sell |
5,126
-203
| -4% | -$213K | 1.06% | 27 |
|
|
2024
Q2 | $5.6M | Buy |
5,329
+425
| +9% | +$447K | 1.56% | 18 |
|
|
2024
Q1 | $4.72M | Buy |
4,904
+590
| +14% | +$568K | 1.32% | 21 |
|
|
2023
Q4 | $3.79M | Sell |
4,314
-202
| -4% | -$177K | 1.31% | 20 |
|
|
2023
Q3 | $3.72M | Buy |
4,516
+243
| +6% | +$200K | 1.45% | 20 |
|
|
2023
Q2 | $3.07M | Buy |
4,273
+767
| +22% | +$551K | 1.31% | 23 |
|
|
2023
Q1 | $2.88M | Sell |
3,506
-189
| -5% | -$155K | 1.36% | 21 |
|
|
2022
Q4 | $2.67M | Buy |
3,695
+191
| +5% | +$138K | 1.5% | 21 |
|
|
2022
Q3 | $2.62M | Sell |
3,504
-283
| -7% | -$212K | 1.49% | 20 |
|
|
2022
Q2 | $2.24M | Buy |
+3,787
| New | +$2.24M | 1.42% | 20 |
|